Total Payments
$21,280
2024 Payments
$3,199
Companies
85
Transactions
1,187
Medicare Patients
5,934
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$21,175 (99.5%)
Education$104.75 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,175 | 1,179 | 99.5% |
| Education | $104.75 | 8 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,879 | 138 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,835 | 95 | $0 (2024) |
| Amgen Inc. | $1,831 | 86 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,528 | 70 | $0 (2024) |
| Novo Nordisk Inc | $1,270 | 75 | $0 (2024) |
| ABBVIE INC. | $1,191 | 59 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,171 | 76 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,128 | 41 | $0 (2024) |
| Merck Sharp & Dohme LLC | $651.51 | 33 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $631.57 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,199 | 152 | Regeneron Healthcare Solutions, Inc. ($425.97) |
| 2023 | $2,856 | 142 | Regeneron Healthcare Solutions, Inc. ($345.09) |
| 2022 | $2,549 | 122 | AstraZeneca Pharmaceuticals LP ($281.95) |
| 2021 | $2,288 | 123 | GlaxoSmithKline, LLC. ($270.26) |
| 2020 | $2,083 | 121 | GlaxoSmithKline, LLC. ($420.48) |
| 2019 | $2,621 | 170 | PFIZER INC. ($421.51) |
| 2018 | $2,723 | 172 | GlaxoSmithKline, LLC. ($395.77) |
| 2017 | $2,960 | 185 | Boehringer Ingelheim Pharmaceuticals, Inc. ($325.97) |
All Payment Transactions
1,187 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $27.09 | General |
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: VACCINE | ||||||
| 12/02/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Cardio-renal | ||||||
| 11/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $0.91 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/25/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: PAIN | ||||||
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.02 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $31.72 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: UROLOGY | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $4.02 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,489 | 18,782 | $1.4M | $555,360 |
| 2022 | 25 | 1,447 | 19,383 | $1.3M | $524,709 |
| 2021 | 24 | 1,521 | 22,033 | $760,541 | $350,357 |
| 2020 | 25 | 1,477 | 6,000 | $442,933 | $199,442 |
Total Patients
5,934
Total Services
66,198
Medicare Billing
$1.6M
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0517 | Injection, benralizumab, 1 mg | Office | 2023 | 11 | 1,710 | $548,850 | $226,236 | 41.2% |
| J1306 | Injection, inclisiran, 1 mg | Office | 2023 | 20 | 9,940 | $248,500 | $93,348 | 37.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 44 | 4,440 | $199,800 | $81,347 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 274 | 611 | $159,565 | $50,947 | 31.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 252 | 252 | $66,664 | $32,989 | 49.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 106 | 206 | $75,262 | $27,383 | 36.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 126 | 130 | $22,146 | $10,400 | 47.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 116 | 116 | $11,600 | $8,794 | 75.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $10,600 | $5,614 | 53.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 104 | 365 | $10,950 | $3,663 | 33.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 118 | 118 | $3,540 | $3,551 | 100.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 46 | $8,442 | $3,218 | 38.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $3,696 | $1,842 | 49.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 26 | 29 | $3,988 | $1,370 | 34.4% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 14 | 16 | $3,200 | $1,166 | 36.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 19 | 25 | $3,340 | $1,150 | 34.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $600.00 | $601.80 | 100.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 43 | 49 | $1,470 | $498.37 | 33.9% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 12 | 15 | $1,476 | $427.13 | 28.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 66 | 550 | $1,238 | $412.27 | 33.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 17 | 62 | $926.00 | $304.60 | 32.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 16 | $480.00 | $54.56 | 11.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 14 | 35 | $140.00 | $40.69 | 29.1% |
| J0517 | Injection, benralizumab, 1 mg | Office | 2022 | 12 | 1,531 | $512,885 | $202,978 | 39.6% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2022 | 11 | 10,920 | $218,190 | $81,531 | 37.4% |
About Dr. Justin Terry, MD
Dr. Justin Terry, MD is a Internal Medicine healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2010. The National Provider Identifier (NPI) number assigned to this provider is 1235453093.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Justin Terry, MD has received a total of $21,280 in payments from pharmaceutical and medical device companies, with $3,199 received in 2024. These payments were reported across 1,187 transactions from 85 companies. The most common payment nature is "Food and Beverage" ($21,175).
As a Medicare-enrolled provider, Terry has provided services to 5,934 Medicare beneficiaries, totaling 66,198 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Henderson, NV
- Active Since 03/23/2010
- Last Updated 07/30/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1235453093
Products in Payments
- NUCALA (Biological) $1,262
- DUPIXENT (Biological) $1,055
- JARDIANCE (Drug) $885.18
- FARXIGA (Drug) $612.09
- FASENRA (Biological) $556.38
- Aimovig (Biological) $498.39
- Ozempic (Drug) $474.09
- CHANTIX (Drug) $471.08
- EVENITY (Biological) $468.05
- NURTEC ODT (Drug) $467.94
- UBRELVY (Drug) $395.01
- VRAYLAR (Drug) $369.12
- Kerendia (Drug) $332.04
- Otezla (Drug) $324.13
- XYOSTED (Drug) $320.11
- REXULTI (Drug) $301.49
- LYRICA (Drug) $297.08
- LINZESS (Drug) $287.01
- Trintellix (Drug) $277.96
- TRINTELLIX (Drug) $272.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Henderson
Ryan Hampton, D.o, D.O
Internal Medicine — Payments: $213,538
Internal Medicine $213,538
Jeffrey Levisman, M.d, M.D
Internal Medicine — Payments: $198,615
Internal Medicine $198,615
Marigene Salazar Sharma, Md, MD
Internal Medicine — Payments: $104,164
Internal Medicine $104,164
Dr. Karthiek Narala, M.d, M.D
Internal Medicine — Payments: $41,673
Internal Medicine $41,673
Sonu Bhatia, M.d, M.D
Internal Medicine — Payments: $21,843
Internal Medicine $21,843
Russell Neibaur, Md, MD
Internal Medicine — Payments: $20,240
Internal Medicine $20,240